Cargando…
Viral and serological kinetics in Zika virus-infected patients in South Korea
Zika virus is a mosquito-borne flavivirus that causes clinical symptoms similar to those observed in dengue and chikungunya virus infections. The Korea Centers for Disease Control and Prevention initiated laboratory testing using a real-time reverse transcription-polymerase chain reaction in January...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383943/ https://www.ncbi.nlm.nih.gov/pubmed/28388922 http://dx.doi.org/10.1186/s12985-017-0740-6 |
_version_ | 1782520374341140480 |
---|---|
author | Jeong, Young Eui Cha, Go-Woon Cho, Jung Eun Lee, Eun Ju Jee, Youngmee Lee, Won-Ja |
author_facet | Jeong, Young Eui Cha, Go-Woon Cho, Jung Eun Lee, Eun Ju Jee, Youngmee Lee, Won-Ja |
author_sort | Jeong, Young Eui |
collection | PubMed |
description | Zika virus is a mosquito-borne flavivirus that causes clinical symptoms similar to those observed in dengue and chikungunya virus infections. The Korea Centers for Disease Control and Prevention initiated laboratory testing using a real-time reverse transcription-polymerase chain reaction in January 2016. More than 1,000 suspected cases of infection were tested and nine were confirmed as imported cases of Zika virus infection from January to July 2016. The travel destinations of the infected individuals were Brazil, Philippines, Viet Nam, Guatemala, Puerto Rico, and the Dominican Republic. Phylogenetic analysis based on the partial envelope gene indicated that the viruses belonged to the Asian genotype circulating in South America. We further investigated the duration for which the viral RNA and virus-specific antibodies were detectable after the symptom onset. After the day of symptom onset, Zika virus was detectable until 6 days in serum, 14 days in urine and saliva, and 58 days in semen. Immunoglobulin M against Zika virus was detected as early as 2 days after the symptom onset and was maintained at these levels until 41 days, whereas Immunoglobulin G was detectable from 8 days after the symptom onset and was maintained until 52 days. These findings would help diagnostic laboratories improve their testing programs for Zika virus infection. |
format | Online Article Text |
id | pubmed-5383943 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-53839432017-04-10 Viral and serological kinetics in Zika virus-infected patients in South Korea Jeong, Young Eui Cha, Go-Woon Cho, Jung Eun Lee, Eun Ju Jee, Youngmee Lee, Won-Ja Virol J Short Report Zika virus is a mosquito-borne flavivirus that causes clinical symptoms similar to those observed in dengue and chikungunya virus infections. The Korea Centers for Disease Control and Prevention initiated laboratory testing using a real-time reverse transcription-polymerase chain reaction in January 2016. More than 1,000 suspected cases of infection were tested and nine were confirmed as imported cases of Zika virus infection from January to July 2016. The travel destinations of the infected individuals were Brazil, Philippines, Viet Nam, Guatemala, Puerto Rico, and the Dominican Republic. Phylogenetic analysis based on the partial envelope gene indicated that the viruses belonged to the Asian genotype circulating in South America. We further investigated the duration for which the viral RNA and virus-specific antibodies were detectable after the symptom onset. After the day of symptom onset, Zika virus was detectable until 6 days in serum, 14 days in urine and saliva, and 58 days in semen. Immunoglobulin M against Zika virus was detected as early as 2 days after the symptom onset and was maintained at these levels until 41 days, whereas Immunoglobulin G was detectable from 8 days after the symptom onset and was maintained until 52 days. These findings would help diagnostic laboratories improve their testing programs for Zika virus infection. BioMed Central 2017-04-07 /pmc/articles/PMC5383943/ /pubmed/28388922 http://dx.doi.org/10.1186/s12985-017-0740-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Short Report Jeong, Young Eui Cha, Go-Woon Cho, Jung Eun Lee, Eun Ju Jee, Youngmee Lee, Won-Ja Viral and serological kinetics in Zika virus-infected patients in South Korea |
title | Viral and serological kinetics in Zika virus-infected patients in South Korea |
title_full | Viral and serological kinetics in Zika virus-infected patients in South Korea |
title_fullStr | Viral and serological kinetics in Zika virus-infected patients in South Korea |
title_full_unstemmed | Viral and serological kinetics in Zika virus-infected patients in South Korea |
title_short | Viral and serological kinetics in Zika virus-infected patients in South Korea |
title_sort | viral and serological kinetics in zika virus-infected patients in south korea |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383943/ https://www.ncbi.nlm.nih.gov/pubmed/28388922 http://dx.doi.org/10.1186/s12985-017-0740-6 |
work_keys_str_mv | AT jeongyoungeui viralandserologicalkineticsinzikavirusinfectedpatientsinsouthkorea AT chagowoon viralandserologicalkineticsinzikavirusinfectedpatientsinsouthkorea AT chojungeun viralandserologicalkineticsinzikavirusinfectedpatientsinsouthkorea AT leeeunju viralandserologicalkineticsinzikavirusinfectedpatientsinsouthkorea AT jeeyoungmee viralandserologicalkineticsinzikavirusinfectedpatientsinsouthkorea AT leewonja viralandserologicalkineticsinzikavirusinfectedpatientsinsouthkorea |